The decrease in equity resulting from the expiry of warrants.

No definition available.

Name:	hiti_DecreaseThroughExpiryOfWarrantsEquity
Namespace Prefix:	hiti_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.

+ References

No definition available.

+ Details

Name:	hiti_IfrsStockIssuedDuringPeriodValueIssuedForServices
Namespace Prefix:	hiti_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The increase (decrease) in equity resulting from the acquisition of assets.

+ References

No definition available.

+ Details

Name:	hiti_IncreaseDecreaseThroughAcquisitionOfAssetsEquity
Namespace Prefix:	hiti_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The increase (decrease) in equity resulting from the acquisition of joint ventures.

+ References

No definition available.

+ Details

Name:	hiti_IncreaseDecreaseThroughAcquisitionOfJointVentureEquity
Namespace Prefix:	hiti_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The increase (decrease) in equity resulting from the equity portion of convertible debentures.

+ References

No definition available.

+ Details

Name:	hiti_IncreaseDecreaseThroughEquityPortionOfConvertibleDebentures
Namespace Prefix:	hiti_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The increase (decrease) in equity resulting from escrow share-based consideration.

+ References

No definition available.

+ Details

Name:	hiti_IncreaseDecreaseThroughEscrowShareBasedConsiderationEquity
Namespace Prefix:	hiti_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The increase (decrease) in equity resulting from extension of convertible debentures.

+ References

No definition available.

+ Details

Name:	hiti_IncreaseDecreaseThroughExtensionOfConvertibleDebentures
Namespace Prefix:	hiti_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The increase (decrease) in equity resulting from the extinguishment of debentures.

+ References

No definition available.

+ Details

Name:	hiti_IncreaseDecreaseThroughExtinguishmentOfDebenturesEquity
Namespace Prefix:	hiti_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The increase (decrease) in equity resulting from vesting of equity instruments other than options.

+ References

No definition available.

+ Details

Name:	hiti_IncreaseDecreaseThroughVestingOfEquityInstrumentsOtherThanOptionsEquity
Namespace Prefix:	hiti_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The increase in equity through the issue of equity instruments for the purpose of interest payments.

+ References

No definition available.

+ Details

Name:	hiti_IssueOfEquityForPaymentOfInterest
Namespace Prefix:	hiti_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The amount of increase (decrease) in equity through purchase of minority interest.

+ References

No definition available.

+ Details

Name:	hiti_PurchaseOfMinorityInterest
Namespace Prefix:	hiti_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The amount of dividends recognised as distributions to owners.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2021-01-01
-Paragraph 107
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_107&doctype=Standard
-URIDate 2021-03-24

+ Details

Name:	ifrs-full_DividendsPaid
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

The amount of residual interest in the assets of the entity after deducting all its liabilities.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 1
-IssueDate 2021-01-01
-Paragraph 24
-Subparagraph a
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2021-en-r&anchor=para_24_a&doctype=Standard
-URIDate 2021-03-24

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 1
-IssueDate 2021-01-01
-Paragraph 32
-Subparagraph a
-Clause i
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2021-en-r&anchor=para_32_a_i&doctype=Standard
-URIDate 2021-03-24

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 13
-IssueDate 2021-01-01
-Paragraph 93
-Subparagraph a
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2021-en-r&anchor=para_93_a&doctype=Standard
-URIDate 2021-03-24

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 13
-IssueDate 2021-01-01
-Paragraph 93
-Subparagraph b
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2021-en-r&anchor=para_93_b&doctype=Standard
-URIDate 2021-03-24

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 13
-IssueDate 2021-01-01
-Paragraph 93
-Subparagraph e
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2021-en-r&anchor=para_93_e&doctype=Standard
-URIDate 2021-03-24

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2021-01-01
-Paragraph 55
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_55&doctype=Standard
-URIDate 2021-03-24

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2021-01-01
-Paragraph 78
-Subparagraph e
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_78_e&doctype=Standard
-URIDate 2021-03-24

+ Details

Name:	ifrs-full_Equity
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

The increase (decrease) in equity resulting from the acquisition of subsidiaries. [Refer: Subsidiaries [member]]

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2021-01-01
-Paragraph 106
-Subparagraph d
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_106_d&doctype=Standard
-URIDate 2021-03-24

+ Details

Name:	ifrs-full_IncreaseDecreaseThroughAcquisitionOfSubsidiary
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The increase (decrease) in equity resulting from the conversion of convertible instruments.

+ References

+ Details

Name:	ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The increase (decrease) in equity resulting from the disposal of subsidiaries. [Refer: Subsidiaries [member]]

+ References

+ Details

Name:	ifrs-full_IncreaseDecreaseThroughDisposalOfSubsidiary
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The increase (decrease) in equity resulting from the exercise of options.

+ References

+ Details

Name:	ifrs-full_IncreaseDecreaseThroughExerciseOfOptions
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The increase (decrease) in equity resulting from the exercise of warrants.

+ References

+ Details

Name:	ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The increase (decrease) in equity resulting from share-based payment transactions. [Refer: Equity]

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2021-01-01
-Paragraph 106
-Subparagraph d
-Clause iii
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_106_d_iii&doctype=Standard
-URIDate 2021-03-24

+ Details

Name:	ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The increase in equity through the issue of equity instruments.

+ References

+ Details

Name:	ifrs-full_IssueOfEquity
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The amount of other comprehensive income, net of tax, after reclassification adjustments, related to exchange differences when financial statements of foreign operations are translated. [Refer: Other comprehensive income]

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2021-01-01
-Paragraph 91
-Subparagraph a
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_91_a&doctype=Standard
-URIDate 2021-03-24

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2021-01-01
-Paragraph 7
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_7&doctype=Standard
-URIDate 2021-03-24

+ Details

Name:	ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 7
-IssueDate 2021-01-01
-Paragraph 18
-Subparagraph b
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_18_b&doctype=Standard
-URIDate 2021-03-24

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 1
-IssueDate 2021-01-01
-Paragraph 24
-Subparagraph b
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2021-en-r&anchor=para_24_b&doctype=Standard
-URIDate 2021-03-24

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 1
-IssueDate 2021-01-01
-Paragraph 32
-Subparagraph a
-Clause ii
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2021-en-r&anchor=para_32_a_ii&doctype=Standard
-URIDate 2021-03-24

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 8
-IssueDate 2021-01-01
-Paragraph 28
-Subparagraph b
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_28_b&doctype=Standard
-URIDate 2021-03-24

Reference 5: http://www.xbrl.org/2003/role/exampleRef
-Note Effective on first application of IFRS 9
-Name IFRS
-Number 4
-IssueDate 2021-01-01
-Paragraph 39L
-Subparagraph e
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=4&code=ifrs-tx-2021-en-b&anchor=para_39L_e&doctype=Standard
-URIDate 2021-03-24

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 8
-IssueDate 2021-01-01
-Paragraph 23
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_23&doctype=Standard
-URIDate 2021-03-24

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Note Effective 2023-01-01
-Name IFRS
-Number 17
-IssueDate 2021-01-01
-Paragraph 113
-Subparagraph b
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_113_b&doctype=Standard
-URIDate 2021-03-24

Reference 8: http://www.xbrl.org/2003/role/exampleRef
-Name IFRS
-Number 12
-IssueDate 2021-01-01
-Paragraph B10
-Subparagraph b
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B10_b&doctype=Appendix&subtype=B
-URIDate 2021-03-24

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2021-01-01
-Paragraph 106
-Subparagraph d
-Clause i
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_106_d_i&doctype=Standard
-URIDate 2021-03-24

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2021-01-01
-Paragraph 81A
-Subparagraph a
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_81A_a&doctype=Standard
-URIDate 2021-03-24

+ Details

Name:	ifrs-full_ProfitLoss
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The amount of cost related to the issuance of shares.

+ References

+ Details

Name:	ifrs-full_ShareIssueRelatedCost
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

Consolidated Statements of Changes in Equity - CAD ($) $ in Thousands	Attributable to owners of the Company KushBar Inc.	Attributable to owners of the Company 2680495 Ontario Inc.	Attributable to owners of the Company Saturninus Partners	Attributable to owners of the Company 102088460 Saskatchewan Ltd.	Attributable to owners of the Company Meta Growth Corp.	Attributable to owners of the Company Smoke Cartel, Inc.	Attributable to owners of the Company Fab Nutrition, LLC.	Attributable to owners of the Company DHC Supply LLC.	Attributable to owners of the Company 102105699 Saskatchewan Ltd.	Attributable to owners of the Company DS Distribution	Attributable to owners of the Company Blessed CBD	Attributable to owners of the Company	Share capital KushBar Inc.	Share capital 2680495 Ontario Inc.	Share capital Saturninus Partners	Share capital 102088460 Saskatchewan Ltd.	Share capital Meta Growth Corp.	Share capital Smoke Cartel, Inc.	Share capital Fab Nutrition, LLC.	Share capital DHC Supply LLC.	Share capital 102105699 Saskatchewan Ltd.	Share capital DS Distribution	Share capital Blessed CBD	Share capital	Warrants Saturninus Partners	Warrants Meta Growth Corp.	Warrants	Contributed surplus Meta Growth Corp.	Contributed surplus	Equity portion of convertible debt Meta Growth Corp.	Equity portion of convertible debt	Accumulated other comprehensive income (loss)	Accumulated deficit KushBar Inc.	Accumulated deficit Fab Nutrition, LLC.	Accumulated deficit Blessed CBD	Accumulated deficit	NCI KushBar Inc.	NCI Saturninus Partners	NCI Meta Growth Corp.	NCI Fab Nutrition, LLC.	NCI Blessed CBD	NCI	KushBar Inc.	2680495 Ontario Inc.	Saturninus Partners	102088460 Saskatchewan Ltd.	Meta Growth Corp.	Smoke Cartel, Inc.	Fab Nutrition, LLC.	DHC Supply LLC.	102105699 Saskatchewan Ltd.	DS Distribution	Blessed CBD	Total
Opening balance at Oct. 31, 2019												$ 9,586												$ 26,283			$ 6,609		$ 2,119		$ 1,637	$ (366)				$ (26,696)						$ (179)												$ 9,407
Fee paid in shares												860												860																														860
Extinguishment of debentures																													1,445		(1,445)
Warrants												98															(913)		1,011																									98
Share-based compensation												129																	129																									129
Equity portion of convertible debentures												1,773																			1,773																							1,773
Cumulative translation adjustment												(121)																				(121)																						(121)
Prepaid Interest paid in shares												1,168												1,168																														1,168
Purchase of minority interest	$ (195)												$ 500																				$ (695)				$ 187						$ (8)
Acquisition of subsidiary		$ 1,048		$ 975									$ 500	$ 1,048	$ 1,064	$ 975					$ 975																							$ 1,048		$ 975
Acquisition of joint venture			$ 1,164												$ 1,064										$ 100													$ 930							$ 2,094
Asset acquisition												104												104																														104
Conversion of convertible debentures												550												550																														550
Net loss												(6,968)																								(6,968)						614												(6,354)
Closing Balance at Oct. 31, 2020												10,171												32,552			5,796		4,704		1,965	(487)				(34,359)						1,552												11,723
Fee paid in shares												467												467																														467
Warrants												16,175												18,257			(2,110)		28																									16,175
Share-based compensation												4,879																	4,879																									4,879
Equity portion of convertible debentures												251																			251																							251
Cumulative translation adjustment												(161)																				(161)																						(161)
Prepaid Interest paid in shares												1,458												1,458																														1,458
Acquisition of subsidiary					$ 47,277	$ 8,396	$ (283)	$ 7,767	$ 2,018	$ 5,013	$ 108						$ 35,290	$ 8,396	$ 3,439	$ 7,767	$ 2,018	$ 5,013	$ 4,432			$ 2,739		$ 240		$ 9,008				$ (3,722)	$ (4,324)				$ 1,821	$ 1,262	$ 864						$ 49,098	$ 8,396	$ 979	$ 7,767	$ 2,018	$ 5,013	$ 972
Conversion of convertible debentures												35,121												45,486							(10,365)																							35,121
Escrow Share based consideration																								9,670												(9,670)
Sale of controlling interest																																										(884)												(884)
Exercise options												1,202												1,534					(332)																									1,202
Warrants expired																											(5,457)		5,457
Extension of convertible debenture												340																	340																									340
Shares and warrants issued through equity financing												46,183												38,566			7,617																											46,183
Share issuance costs												(3,456)												(5,595)			2,139																											(3,456)
Vesting Of RSUs																								154					(154)
Partner distributions																																										500												500
Net loss												(35,717)																								(35,717)						680												(35,037)
Closing Balance at Oct. 31, 2021												$ 147,209												$ 208,904			$ 10,724		$ 15,162		$ 859	$ (648)				$ (87,792)						$ 4,795												$ 152,004